New incident report
Incident Report Number: 2021-2658
Registrant Reference Number: 2020-CA-000195
Registrant Name (Full Legal Name no abbreviations): The Hartz Mountain Corporation
Address: 400 Plaza Drive
City: Secaucus
Prov / State: New Jersey
Country: USA
Postal Code: 07094-3688
Domestic Animal
Country: CANADA
Prov / State: QUEBEC
PMRA Registration No. 25620 PMRA Submission No. EPA Registration No.
Product Name: Hartz UltraGuard Flea and Tick Collar for Dogs
Yes
Unknown
Site: Animal / Usage sur un animal domestique
Animal's Owner
Dog / Chien
Boston Terrier
1
Female
4
7.26
kg
Skin
>24 hrs <=3 days / >24 h <=3 jours
>24 hrs <=3 days / >24 h <=3 jours
System
Unknown / Inconnu
No
No
Unknown/Inconnu
Treatment / Traitement
(eg. description of the frequency and severity of the symptoms
On 13-Jun-2020, a 4 year old, 7.26 kilogram, neutered, female, Boston Terrier dog, in unknown condition, with no known concomitant medical conditions, was administered 1 collar of Hartz UltraGuard Flea and Tick Collar for Dogs (Tetrachlorvinphos) via the topical route by the animal owner. on 15-Jun-2020, the dog developed diarrhea, lethargy and vomited once. The collar was removed by the animal owner and the dog was fed a bland diet of ground turkey and rice. On 19-Jun-2020, the dog's skin felt warm to the touch. On an unspecified date, the pet owner spoke with a veterinarian and a fecal exam was recommended. The clinical signs continued. Veterinary evaluation was recommended for persistent clinical signs. No further information was received in this case.
Moderate
Assessment: If the collar were licked by the dog or if a small amount of the collar was ingested, minor GI irritation resulting in vomiting, diarrhea, and inappetance may occur. The persistent signs described are not expected, especially in the absence of ingestion of the product. Other causes including dietary indiscretion, intestinal parasites, and viral infection should also be considered. The information contained in this report is based on self-reported statements provided to the registrant during telephone interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and cannot form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews.